Samir K Ballas; Franca B Barton; Myron A Waclawiw; Paul Swerdlow; James R Eckman; Charles H Pegelow; Mabel Koshy; Duane R Bonds Baseline QOL results were available on all 299 MSH patients ...

SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...

New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.

Hydroxyurea Significantly Reduces Infections in Children With Sickle Cell Anemia Jan. 29, 2024 — Researchers have revealed that hydroxyurea significantly reduces infections in children with ...

BabyHUG = Baby Hydroxyurea Group; BP = blood pressure; CPAP/O 2 = continuous positive airways pressure/oxygen; LDH = lactate dehydrogenase; POMS = Prevention of Morbidity in Sickle Cell Disease ...

We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...

Sickle cell disease is a group of congenital red ... to relieve symptoms as well as antibiotics to treat infections, hydroxyurea—a bone marrow suppressive agent that decreases red blood cell ...

Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps ...

Once it’s diagnosed, sickle cell disease is managed with hydroxyurea, a medication that reduces the frequency of pain and the need for blood transfusions. Children younger than 5 also receive ...